Trade Summary

Yesterday, Ring Christine, serving as Chief Legal Officer at Nurix Therapeutics, Inc. (NRIX), sold 5,787 shares at $25.76 per share, for a total transaction value of $149,072.35. Following this transaction, Ring Christine now holds 9,110 shares of NRIX.

This sale represents a 38.85% decrease in Ring Christine's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, September 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 2, 2026 at 7:42 PM ET, meaning the disclosure happened on the same day as the trade.

Nurix Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.